Pfizer Inc. DRC (PFE)

8,053.50
-89.00(-1.09%)
  • Volume:
    7,648
  • Bid/Ask:
    8,023.00/8,053.50
  • Day's Range:
    8,018.00 - 8,240.00
Unusual trading volume

Pfizer DRC has doubled (or more) its daily average of shares traded over the last 3 months. High volumes usually indicate new trends and larger share price movements.

PFE Overview

Prev. Close
8,142.5
Day's Range
8,018-8,240
Revenue
76.04B
Open
8,200
52 wk Range
4,512.5-9,312.5
EPS
5.31
Volume
7,648
Market Cap
46.49T
Dividend (Yield)
0.82
(1.85%)
Average Vol. (3m)
3,384
P/E Ratio
8.31
Beta
0.651
1-Year Change
37.44%
Shares Outstanding
5,613,314,537
Next Earnings Date
-
What is your sentiment on Pfizer DRC?
or
Market is currently closed. Voting is open during market hours.

Pfizer Inc. DRC News

Pfizer Inc. DRC Analysis

Pfizer Inc. DRC Company Profile

Pfizer Inc. DRC Company Profile

Employees
79000
Market
Argentina

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women’s health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellSellStrong Buy
Technical IndicatorsSellSellStrong SellSellStrong Buy
SummaryStrong SellStrong SellStrong SellSellStrong Buy